November 30, 2018
Pipeline Portfolio has been updated.
May 11, 2018
Announcement of Phase 2 trial results of Imarikiren (SCO-272) at the 55th ERA-EDTA CONGRESS236 KB
October 27, 2017
Announcement of Phase 1 study results of Imarikiren (SCO-272) at the 38th Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics383 KB